The Maharashtra Food and Drug Administration (FDA) has officially suspended the operating licenses of three blood banks located in Mumbai. The regulatory action follows an investigation into reports that these facilities were providing gifts or other incentives to individuals in exchange for blood donations.

Under Indian regulations, blood donation is intended to be a voluntary, altruistic act. Offering financial rewards, gifts, or material incentives to donors is strictly prohibited by the Drugs and Cosmetics Act, 1940, and the National Blood Transfusion Council guidelines. Regulators argue that such practices can compromise the safety of the blood supply by encouraging donors to potentially hide health issues or medical history in order to receive the offered incentives.

While the specific identities of the three blood banks have not been widely publicized in initial reports, the FDA has stated that the suspension is a direct response to violations of these ethical and safety standards. The suspension effectively bars these facilities from collecting, processing, or distributing blood until they can demonstrate compliance with regulatory requirements. The FDA has indicated that it will continue to monitor blood banks across the city to ensure that donation practices remain strictly voluntary and free from commercial influence. There is currently no information regarding whether the facilities intend to appeal the decision or if further legal penalties will be pursued beyond the license suspension.